Abstract
The clinical status and treatment response of patients with peripheral neuropathies (PN) rely on subjective and inaccurate clinical scales. Wearable sensors have shown success in evaluating gait and balance in individuals with other neurological disorders. We aimed to explore the ability of biomechanical analysis via wearable technology to monitor disease activity in PN by conducting a single-center, longitudinal study to analyze gait parameters in PN patients and healthy controls using wearable sensors. First, we analyzed the sensor’s ability to detect changes in ataxia and steppage gait severity and found significant differences in spatiotemporal and angular variables. Second, we found correlations between biomechanical features and clinical scales linked to specific gait phenotypes. Finally, we demonstrated that this technology captures clinical changes in gait features over time. Our study provides proof-of-concept that wearable technology effectively detects and grades gait impairment, captures clinically relevant changes, and could enhance gait assessment in routine care and research for PN patients.
Competing Interest Statement
L.Q received research grants from UCB and Grifols; received speaker or expert testimony honoraria from CSL Behring, Novartis, Sanofi-Genzyme, Merck, Annexon, Alnylam, Biogen, Janssen, Lundbeck, ArgenX, UCB, LFB, Octapharma and Roche; serves at the Clinical Trial Steering Committee for Sanofi-Genzyme and Roche; and is Principal Investigator for UCB CIDP01 trial. J.P, M.C.M, A.P.C, A.H.D, J.G.F and S.I.Z are employed by Ephion Health, the company that provided the software and performed the analyses for this study. Ephion Health has commercial interest in the software used in this research. However, the Neuromuscular Diseases Unit maintained full control over the design, data collection, and interpretation of the clinical results. All other authors report no disclosures relevant to the manuscript.
Funding Statement
This work was supported by Fondo de Investigaciones Sanitarias (FIS), instituto de Carlos III, Spain, under grant PI22/00387. C.T.I was supported by a personal PFIS grant FI23/00171. M.C.A was supported by a personal Rio Hortega grant CM21/00101. L.M.A was supported by a personal Juan Rodes grant JR21/00060. E.P.G was supported by a personal grant from the GBS-CIDP foundation. A.C was supported by a personal Rio Hortega grant CM21/00057. L.Q was supported by a personal clinical intensification INT23/00066, a GBS/CIDP Foundation International Research Grant in 2020, and research grants from CIBERER and Fundació La Marató.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was conducted according to a protocol approved by the Ethics Committee of the Hospital de la Santa Creu i Sant Pau (code IIBSP-NMI-2019-107). All patients provided written informed consent to participate in the study.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data availability
The datasets generated and/or analyzed during the current study are available from the corresponding author upon reasonable request.
